Ellume has announced two recent global partnerships ­ one in December with global healthcare group GlaxoSmithKline (GSK) focused on improving respiratory care, and a second this month with QIAGEN N.V. which is developing an advanced test for tuberculosis (TB) incorporating Ellume's diagnostic capabilities. These partnerships illustrate the performance-enhancing capabilities of AnteoBind. The integration of the technology into POC systems, similar to those being developed by partners such as Ellume, demonstrates the supporting role Anteo is playing by supplying valuable components that then enable superior performance of diagnostic systems.